Log in
Log in
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
Sign up
Or log in with
GoogleGoogle
Twitter Twitter
Facebook Facebook
Apple Apple     
  1. Homepage
  2. Equities
  3. Japan
  4. Japan Exchange
  5. Eisai Co., Ltd.
  6. News
  7. Summary
    4523   JP3160400002

EISAI CO., LTD.

(4523)
  Report
Delayed Japan Exchange  -  10:32 2022-11-28 pm EST
8688.00 JPY   -9.35%
10:42aBiogen Shares Fall After Report of Death Linked to Potential Treatment for Alzheimer's Disease
MT
11/24Eisai to present latest data on fycompa ciii at the 76th american epilepsy society annual meeting
AQ
11/23Eisai to Present Latest Data on Perampanel at the 76th American Epilepsy Society (AES) Annual Meeting
AQ
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisionsFunds 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector newsMarketScreener Strategies
Days
:
Hours
:
Minutes
:
Seconds

Japan's Nikkei ends at near 3-month low on global recession fears

09/28/2022 | 03:02am EST

TOKYO, Sept 28 (Reuters) - Japan's Nikkei share average ended at a near three-month low on Wednesday, amid worsening recession fears hitting Wall Street overnight, while a media report that Apple dropped plans of producing more iPhones also weighed on sentiment.

The Nikkei fell 1.5% to close at 26,173.98, after hitting a July 1 low of 25,938.36 earlier.

The benchmark index had opened weak and it fell further following a Bloomberg News report that Apple would drop a plan to boost production of its new smartphones after an anticipated demand surge failed to materialise.

Investors globally are on edge as surging borrowing costs stoke fears of widespread recession, with most of the world's major central banks putting their focus squarely on tightening policies to contain super-heated inflation.

"It's very hard to buy stocks in a situation where everyone is working to gauge the risk of sliding into recession," said Jun Kitazawa, a strategist at Miki Securities.

Of the benchmark's 225 constituents, 206 stocks fell and 19 rose.

The broader Topix slid 0.95% to 1,855.15.

Pharma was the only Nikkei sector that rose, adding 0.35%.

Eisai surged by its daily limit, rising 17.29% after the drugmaker reported successful trial of its experimental Alzheimer's treatment lecanemab.

Rival Shionogi added 1.08% after saying its oral treatment for COVID-19 demonstrated a significant reduction in symptoms compared to a placebo.

Real estate led declines among other sectors, dropping 2.78%.

The biggest drag on the Nikkei by index weight share was Uniqlo store operator Fast Retailing, down 4.23%, followed by robotics giant Fanuc, 2.89% lower, startup investor SoftBank Group, off 1.83%, and chip-making equipment-maker Tokyo Electron, which lost 1.38%.

Apple supplier TDK was next, declining 3.05%. (Reporting by Kevin Buckland; Additional reporting by Tokyo markets team; Editing by Subhranshu Sahu)


ę Reuters 2022
Stocks mentioned in the article
ChangeLast1st jan.
ACCENT GROUP LIMITED 2.38% 1.72 Delayed Quote.-31.22%
APPLE INC. -2.63% 144.22 Delayed Quote.-16.59%
EISAI CO., LTD. -9.48% 8688 Delayed Quote.44.97%
FANUC CORPORATION 0.15% 20475 Delayed Quote.-16.00%
FAST RETAILING CO., LTD. 1.09% 81200 Delayed Quote.22.32%
NIKKEI 225 -0.42% 28162.83 Real-time Quote.-1.77%
SHIONOGI & CO., LTD. -0.36% 6998 Delayed Quote.-12.26%
SOFTBANK GROUP CORP. -1.79% 5925 Delayed Quote.11.87%
TDK CORPORATION -1.21% 4880 Delayed Quote.10.36%
TOKYO ELECTRON LTD. -0.79% 44950 Delayed Quote.-30.57%
TOPIX INDEX -0.65% 1990.79 Delayed Quote.1.29%
All news about EISAI CO., LTD.
10:42aBiogen Shares Fall After Report of Death Linked to Potential Treatment for Alzheimer's ..
MT
11/24Eisai to present latest data on fycompa ciii at the 76th american epilepsy society annu..
AQ
11/23Eisai to Present Latest Data on Perampanel at the 76th American Epilepsy Society (AES) ..
AQ
11/23Eisai to Present Latest Data on Fycompa CIII at the 76th American Epilepsy Society Annu..
CI
11/22To Develop Japan's First Blood Biomarker-Based Diagnostic Workflow for Dementia Shimadz..
AQ
11/20Eisai to Present Full Findings from Lecanemab Confirmatory Phase 3 Clinical Trial (Clar..
AQ
11/18Interest-Rate Outlook Undercuts Tokyo Equities as Japan Inflation Hits 40-Year High
MT
11/16Metoject Subcutaneous Injection Syringe (Methotrexate) Launched In Japan For Rheumatoid..
AQ
11/15Bank Stocks, Stronger Yen Drive Tokyo Equities Into Green
MT
11/15Casma Therapeutics, Inc. announced that it has received $46 million in funding from a g..
CI
More news
Financials
Sales 2023 738 B 5 311 M 5 311 M
Net income 2023 57 998 M 418 M 418 M
Net cash 2023 198 B 1 425 M 1 425 M
P/E ratio 2023 49,2x
Yield 2023 1,69%
Capitalization 2 750 B 19 801 M 19 801 M
EV / Sales 2023 3,46x
EV / Sales 2024 3,23x
Nbr of Employees 11 322
Free-Float 93,3%
Chart EISAI CO., LTD.
Duration : Period :
Eisai Co., Ltd. Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends EISAI CO., LTD.
Short TermMid-TermLong Term
TrendsBullishBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus HOLD
Number of Analysts 13
Last Close Price 9 584,00 JPY
Average target price 8 461,54 JPY
Spread / Average Target -11,7%
EPS Revisions
Managers and Directors
Haruo Naito Manager-Research & Development Promotions
Tatsuyuki Yasuno Manager-Corporate Planning
Yasuhiko Katoh Chairman
Keisuke Naito Executive Officer & Head-Global IT Headquarters
Yasushi Okada Manager-Business Planning
Sector and Competitors
1st jan.Capi. (M$)
EISAI CO., LTD.44.97%19 511
JOHNSON & JOHNSON3.66%463 391
ELI LILLY AND COMPANY32.23%347 052
ABBVIE INC.17.01%282 189
PFIZER, INC.-16.05%276 231
MERCK & CO., INC.41.51%272 555